RE:i am surprisedYa - people are unaware and uninterested at this time.
All good ! I'm not one for fanfare anyway.
Financials are likely out around June 28th.
That's also likely the time that we get a full drug development update.
Could it come sooner ? Sure.
But it's safer to assume we wait until June 28th and anything earlier is just a bonus.
-----------------------------
Are we actually getting a drug development update this time?
Is a patent for IBD underway?
Has IBD gone through its paces as a chronic-type drug and how is it going to deal with the liver issue?
Does IBD tell us anything about OTENA-chronic?
Will IBD coat the entire intestine or only part to protect biofilm (difference between Crohn's, Colitis or both)?
How many other purposes will OTENA-Acute cover ... pre-op?
Are we going to hear about an OTENA-Acute-IV form for intra-op?
What does the chronic plan look like? Is it too early to discuss this?
What about 352 ... has a decision been made on direction?
Is it too early to talk about Antiviral? Does that need reformulation or has it already happened?
So many things on the go - what are they prepared to discuss?
Exciting 2023? Let's see if we're finally there.